18 related articles for article (PubMed ID: 3895397)
1. Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer.
Mytar B; Zembala M; Uracz W; Czupryna A
Cancer Immunol Immunother; 1982; 13(3):190-3. PubMed ID: 6219736
[TBL] [Abstract][Full Text] [Related]
2. The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.
Espevik T; Kildahl-Andersen O; Nissen-Meyer J
Immunology; 1986 Feb; 57(2):255-9. PubMed ID: 3081437
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.
Tanaka H; Abe E; Miyaura C; Shiina Y; Suda T
Biochem Biophys Res Commun; 1983 Nov; 117(1):86-92. PubMed ID: 6581807
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
Reichel H; Koeffler HP; Norman AW
Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
[TBL] [Abstract][Full Text] [Related]
7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3-differentiated human promyelocytic leukaemia cells (HL-60) can kill antibody-coated tumour cells (K562).
Espevik T
Scand J Immunol; 1985 Jul; 22(1):105-9. PubMed ID: 3895397
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.
Hughes PJ; Marcinkowska E; Gocek E; Studzinski GP; Brown G
Leuk Res; 2010 May; 34(5):553-65. PubMed ID: 19811822
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
